Inflammatory response in the non-small cell lung tissue and its regulation for cancer treatment
非小细胞肺组织的炎症反应及其对癌症治疗的调节
基本信息
- 批准号:15591479
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Exp. 1:Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine derived from T cells and the pituitary gland. However, several types of solid cancers also secrete MIF, and this factor has been suggested to play an important role in carcinogenesis and the progression of malignancy. In this study, we quantified MIF mRNA expression of non-small cell lung cancer (NSCLC) tissues, and examined its relationship with clinicopathologic factors.Method: MIF mRNAs of both tumor and normal tissues were quantified by a real-time monitoring reverse transcription polymerase chain reaction in 59 patients with NSCLC. The relationship between the grade of MIF expression and clinicopathologic factors such as smoking history, cell type, stage, and prognosis was examined to investigate the clinical significance of intratumoral expression of MIF.Results: The mean copy number of MIF mRNA per 0.08 μg of total mRNA in tumor tissues was 144078.00, whereas that of normal lung tissue was 25438.46 … More (p< 0.0001). The amounts of MIF proteins revealed by a Western blot analysis were well correlated with those of the corresponding mRNAs. Male patients and heavy smokers showed significantly higher expression of MIF. And patients with squamous cell carcinomas showed a higher expression of MIF mRNA than other subjects. In squamous cell carcinoma patients, higher expression of MIF mRNA was significantly associated with unfavorable prognosis (p=0.0142).In a lung cancer cell line, PC9, tobacco smoke solution or benzo(a) pyrene induced MIF protein at a time-dependent manner.Conclusions : The general intratumoral expression and close relation to smoking suggested that MIF might contribute to tumorigenesis in the lung.Exp. 2From the results of the Exp. 1, it was suggested that cigarette smoke induced inflammatory cytokines such as MIF, and clinical survey of relationship between smoking status and postoperative prognosis in patients with non-small cell lung cancer.Methods: Lung adenocarcinoma cell lines (A549) were exposed to benzo(a)pyrene (B(a)P) for 24 weeks, and morphology, proliferative activity, and gene expression profiles were analyzed.Results: Although no apparent morphologic changes were observed, the B(A)P-exposed A549 exhibited enhanced proliferative activity in 1 % bovine serum medium, and dramatic changes in expression levels were observed in a large number of genes. Of them, epithelial-to-mesenchymal transition (EMT)-related genes such as migration stimulating factor, plasminogen activator-inhibitor, twist, transforming growth factor-beta, and basic fibroblast growth factor. Most enhanced expression levels remained 8 weeks after the retrieval of B(A)P in culture.Conclusions: B(a)P, which is one of the strongest carcinogens included in tobacco smoke, can induce EMT-related genes in lung cancer cells. This results indicate tobacco enhanced multiple factors including inflammatory cytokines (TGF-beta) and may drive malignant potential of lung cancer. Less
实验1:巨噬细胞迁移抑制因子(Macrophage migration inhibitory factor, MIF)是一种来源于T细胞和脑垂体的促炎细胞因子。然而,几种类型的实体癌也分泌MIF,并且该因子已被认为在癌变和恶性肿瘤进展中发挥重要作用。本研究通过定量分析非小细胞肺癌(NSCLC)组织中MIF mRNA的表达,并探讨其与临床病理因素的关系。方法:采用逆转录聚合酶链反应实时监测59例非小细胞肺癌患者肿瘤和正常组织的MIF mrna。观察MIF表达等级与吸烟史、细胞类型、分期、预后等临床病理因素的关系,探讨MIF在瘤内表达的临床意义。结果:肿瘤组织中MIF mRNA每0.08 μg拷贝数为144078.00,正常肺组织中MIF mRNA每0.08 μg拷贝数为25438.46…More (p< 0.0001)。Western blot分析显示MIF蛋白的数量与相应mrna的数量有很好的相关性。男性患者和重度吸烟者MIF表达明显增高。鳞状细胞癌患者的MIF mRNA表达高于其他受试者。在鳞状细胞癌患者中,MIF mRNA的高表达与不良预后显著相关(p=0.0142)。在肺癌细胞系中,PC9、烟草烟雾溶液或苯并(a)芘诱导MIF蛋白呈时间依赖性。结论:MIF在肿瘤内的普遍表达及其与吸烟的密切关系提示MIF可能参与肺部肿瘤的发生。2实验1的结果提示吸烟诱导炎性细胞因子如MIF,吸烟状况与非小细胞肺癌患者术后预后关系的临床调查。方法:将肺腺癌细胞(A549)暴露于苯并(a)芘(B(a)P)中24周,分析其形态、增殖活性和基因表达谱。结果:暴露于B(A) p的A549在1%牛血清培养基中增殖活性增强,大量基因表达水平发生显著变化,但未观察到明显的形态学变化。其中,上皮-间质转化(EMT)相关基因如迁移刺激因子、纤溶酶原激活因子-抑制剂、twist、转化生长因子- β、碱性成纤维细胞生长因子等。在培养中提取B(A)P后8周,大多数增强表达水平保持不变。结论:B(a)P是烟草烟雾中最强的致癌物之一,可诱导肺癌细胞中emt相关基因的表达。这些结果表明,烟草增加了包括炎症细胞因子(tgf - β)在内的多种因子,并可能驱动肺癌的恶性潜能。少
项目成果
期刊论文数量(25)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Induction of epithelial-mesenchymal transition-related genes by benzo(a) pyrene in lung cancer.
肺癌中苯并(a)芘诱导上皮间质转化相关基因。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Yoshino I;et. al.
- 通讯作者:et. al.
Glycolytic potential of non-small cell lung cancer:implication of anaerobic glycolysis on malignant potential
非小细胞肺癌的糖酵解潜能:无氧糖酵解对恶性潜能的影响
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Yoshino I;et. al.
- 通讯作者:et. al.
Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer
- DOI:10.1200/jco.2004.01.035
- 发表时间:2004-10-15
- 期刊:
- 影响因子:45.3
- 作者:Osoegawa, A;Yoshino, I;Maehara, Y
- 通讯作者:Maehara, Y
Smoking status as a prognostic factor in patients with stage pulmonary adenocarcinoma
吸烟状况作为肺腺癌患者的预后因素
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Yoshino I;et. al.
- 通讯作者:et. al.
Glycolytic potential of non-small cell lung cancer : implication of anaerobic glycolysis on malignant potential
非小细胞肺癌的糖酵解潜力:无氧糖酵解对恶性潜力的影响
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Yoshino I;et. al.
- 通讯作者:et. al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOSHINO Ichiro其他文献
YOSHINO Ichiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOSHINO Ichiro', 18)}}的其他基金
Translational research for lung regenerative treatment by cell transplantation
细胞移植肺再生治疗的转化研究
- 批准号:
23390312 - 财政年份:2011
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of local regulation strategy for malignant pleural mesothelioma
恶性胸膜间皮瘤局部调控策略的制定
- 批准号:
19591629 - 财政年份:2007
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Induction of Tumor-specific Cytotoxic Tlymphocytes from Regional Lymph Node Lymphocytes of Human Breast Cancer
人乳腺癌区域淋巴结淋巴细胞诱导肿瘤特异性细胞毒性T淋巴细胞
- 批准号:
09671269 - 财政年份:1997
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 2.05万 - 项目类别:
人口知能を用いたCT画像に基づくLung Cancer mimicking Organizing Pneumonia の診断
利用人工智能基于CT图像模拟组织性肺炎的肺癌诊断
- 批准号:
24K18841 - 财政年份:2024
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Epigenomic Methods to Improve Personalised Treatment in Patients with Lung Cancer and Malignant Pleural Effusion.
表观基因组方法改善肺癌和恶性胸腔积液患者的个体化治疗。
- 批准号:
MR/X030938/1 - 财政年份:2024
- 资助金额:
$ 2.05万 - 项目类别:
Research Grant
Living in limbo: The Experience of and Relationship between Fear of Progression, Illness Uncertainty, Symptom Burden, and Death Anxiety in Patients with Advanced or Metastatic Lung Cancer Receiving Immunotherapy or Targeted Therapy
生活在不确定之中:接受免疫治疗或靶向治疗的晚期或转移性肺癌患者对病情进展的恐惧、疾病的不确定性、症状负担和死亡焦虑的经历和关系
- 批准号:
478587 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Operating Grants
Advanced Raman Spectroscopy for Exhaled Breath Analysis for Lung Cancer Detection
用于肺癌检测的呼出气体分析的先进拉曼光谱
- 批准号:
494958 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Operating Grants
Lung cancer therapy using genetically modified macrophages
使用转基因巨噬细胞治疗肺癌
- 批准号:
488420 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Operating Grants
Study of the mechanisms of lung cancer development through multi-omics analysis of normal tissues and precancerous lesions of the lung
通过肺部正常组织和癌前病变的多组学分析研究肺癌发生的机制
- 批准号:
23H02758 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a novel therapeutic strategy targeting the microenvironment that tolerates the progression of refractory lung cancer
开发针对难治性肺癌进展的微环境的新型治疗策略
- 批准号:
23H02996 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of highly accurate diagnostic method using photodynamic diagnosis of aminolevulinic acid for lung cancer pleural disseminated lesions
氨基乙酰丙酸光动力诊断肺癌胸膜播散性病变高精度诊断方法的开发
- 批准号:
23K08286 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a new lung cancer therapy targeting a MAML3-Hh/NOTCH signaling pathway
开发针对 MAML3-Hh/NOTCH 信号通路的新型肺癌疗法
- 批准号:
23K08298 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)